Strategies for Modifying High-Density Lipoprotein Cholesterol: A Role for Nicotinic Acid

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.19, Iss.6, 2005-12, pp. : 415-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HMG-CoA Reductase Inhibitor (Statin) Therapy and Coronary Atherosclerosis in Japanese Subjects: Role of High-Density Lipoprotein Cholesterol

By Tani Shigemasa Nagao Ken Hirayama Atsushi

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 411-417

Adis International

Access to resources Recommend Favorite

High-Density Lipoprotein-Raising Strategies: Update 2010

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1517-1530

Bentham Science Publishers

Access to resources Recommend Favorite

Should We Take High-Density Lipoprotein Cholesterol Levels at Face Value?

By > >

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 1-3

Adis International

Access to resources Recommend Favorite

Potential therapeutic agents that raise high-density lipoprotein cholesterol levels

By Rodriguez Annabelle Doshi Rajiv R

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 167-175

Informa Healthcare

Access to resources Recommend Favorite

High-Density Lipoprotein: Key Molecule in Cholesterol Efflux and the Prevention of Atherosclerosis

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1445-1467

Bentham Science Publishers

Access to resources Recommend Favorite